Oncology

Latest News

The new report suggests the C5a-C5aRq axis might be a useful target in combination with existing therapies for cutaneous squamous cell carcinoma. | Image credit: vladimircaribb - stock.adobe.com

C5aR1 Flagged as Biomarker in Cutaneous Squamous Cell Carcinoma

By Jared Kaltwasser

June 7th 2025

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

The study identified several molecular markers related to SCLC prognosis by integrating somatic mutation profiles, mRNA transcriptome data, and clinical information. | Image credit: vitstudio - stock.adobe.com

Novel Biomarkers May Inform Prognosis in SCLC

By AJMC Contributor

June 6th 2025

Structured exercise programs should be a part of the standard of care for colon cancer following adjuvant chemotherapy, authors of the COMMANDS study recommended. | Image credit: Drazen - stock.adobe.com

Structured Exercise Program Improves Outcomes, Quality of Life in Colon Cancer

By Rose McNulty

June 6th 2025

young adult cancer | Image credit: Roswell Park Cancer Center

ASCO Sessions Explore Data and Dynamics of Early-Onset Cancer

By Mary Caffrey

June 6th 2025

FDA headquarters | Image Credit: - Tada Images- stock.adobe.com

5 Key FDA Approval Dates Mark a Milestone-Filled May

By Brooke McCormick

June 6th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

stethoscope on charts - amazing studio - stock.adobe.com

December 8th 2023

California Aims for Equity by Redefining Cancer Care

Giuliana Grossi

Authors highlight key aspects of the California Cancer Care Equity Act, including its focus on Medi-Cal beneficiaries, the requirement for managed care plans to contract with specialized cancer centers, and the definition of complex cancers.

Quit Smoking - s@photo - stock.adobe.com

December 7th 2023

Research Reveals the Role of Structural Racism in Lung Cancer Risk

Giuliana Grossi

Spanning 22 studies, the analysis illuminated housing disparities, occupational hazards, unequal health care access, economic inequality, and discriminatory industry practices and how they collectively contribute to heightened lung cancer risks.

December 2nd 2023

FDA Grants Priority Review to Enfortumab Vedotin + Pembrolizumab in Metastatic Urothelial Cancer

Jordyn Sava

Positive data from the phase 3 EV-302 trial of enfortumab vedotin with pembrolizumab in locally advanced or metastatic urothelial cancer have shifted the landscape.

Hospital | Image credit: Andrii - stock.adobe.com

December 1st 2023

Gaps in Access to Cancer Care Resources May Contribute to Racial, Ethnic Disparities

Rose McNulty

Researchers found that core oncology services were less likely to be available at hospitals serving racial and ethnic minority groups compared with other hospitals in the United States.

empty prescription bottle | Image credit: Diomedes de jesus - stock.adobe.com

November 21st 2023

IQVIA Report Spotlights Shortages for Pain, Obesity, and Oncology Therapies

Skylar Jeremias

A new report from IQVIA provides an overview of current US drug shortages, shedding light on major areas of concern, such as medications to address pain, cardiovascular conditions, obesity and diabetes, and multiple forms of cancer.

November 17th 2023

Dr Alyson Moadel-Robblee on Effective Distress Screening and Support Systems for Patients With Cancer

Pearl Steinzor Rose McNulty

Alyson Moadel-Robblee, PhD, deputy director of community engagement and cancer health equity at Montefiore Einstein Comprehensive Cancer Center, discussed the center's evolving patient distress screening process and the Bronx Oncology Living Daily support program for patients with cancer.

November 16th 2023

Nashville Oncology Associates Now Part of The US Oncology Network

The US Oncology Network now has more than 2400 providers who treat over 1.4 million patients annually at approximately 600 sites of care in 30 states.

Ian Flinn, MD, PhD | Image credit: Tennessee Oncology

November 16th 2023

Ian Flinn, MD, PhD, to Serve as Chief Scientific Officer for Greco-Hainsworth Tennessee Oncology Centers for Research

AJMC Staff

The centers for research are named for Anthony Greco, MD, and John Hainsworth, MD, who founded Sarah Cannon in 1993 as Tennessee Oncology physician researchers.

Female patient and doctor - Dragana Gordic - stock.adobe.com

November 14th 2023

Racial Discrimination in Cancer Care Has Long-Term Impact on Patients, Study Shows

Giuliana Grossi

“The silencing of Black cancer patient voices impacted patients’ health care utilization and had implications for their physical health,” the authors wrote.

November 10th 2023

Overcoming Challenges to Value-Based Care Implementation: Grant Andres

Rose McNulty

In an interview with The American Journal of Managed Care®, Grant Andres, BSc, DC, BSN, MSN-RN, senior director of clinical operations at Arizona Oncology, discussed the nuances of successfully implementing value-based care initiatives across a large organization.

November 2nd 2023

Dr Amy Laughlin on the Benefits of At-Home Cancer Care

Brooke McCormick

Amy Laughlin, MD, MSHP, of Orlando Health gave a preview of the topic she is presenting on at today's American Journal of Managed Care®’s Institute for Value-Based Medicine® event in New York City.

November 1st 2023

Dr Kathi Mooney Previews Oncology Hospital at Home Presentation

Brooke McCormick

Kathi Mooney, PhD, RN, FAAN, of the University of Utah, gave a preview of "The Oncology Hospital at Home," the presentation she is giving at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on November 2 in New York City.

October 30th 2023

Dr Saira Jan Details Current, Future Cost Savings From Oncology Therapeutics Home Infusion Program

Brooke McCormick

Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, discussed cost savings that occurred so far from their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health and also noted those they predict to occur as the program continues.

October 27th 2023

Collaboration Is Key to Execute Value-Based Care for Patients With Cancer

Rose McNulty

Coverage of the Institute for Value-Based Medicine session with Zangmeister Cancer Center, Columbus, Ohio.

October 27th 2023

Dr Saira Jan Explains Oncology Therapeutics Home Infusion Pilot Program

Brooke McCormick

Saira Jan, PharmD, MS, of Horizon Blue Cross Blue Shield of New Jersey, provides an overview of their collaborative pilot program with Rutgers Cancer Institute of New Jersey and RWJ Barnabas Health, discussing the program's origin, objectives, and beyond.

October 26th 2023

Multiple Perspectives of Managing Cancer From the Multidisciplinary Team at Vanderbilt

Laura Joszt, MA

Coverage from the Institute for Value-Based Medicine event with Vanderbilt University Medical Center.

October 26th 2023

Raising the Bar for Precision Oncology and Clinical Research in a Community Practice Setting

Mary Caffrey

Coverage from the Institute for Value-Based Medicine session with Florida Cancer Specialists & Research Institute.

October 25th 2023

Business Highlights From Partners in Community Oncology

AJMC Staff

October 25th 2023

OneOncology Finalizes 25 Clinical Pathways in Oncology and Hematology

AJMC Staff

October 25th 2023

COA’s Policy Agenda Gains Steam on Capitol Hill, as the House Elects a Speaker

Mary Caffrey

There is bipartisan support in the Congress for the Community Oncology Alliance's (COA) key agenda items, with hope that some will pass by year’s end.

Ted Okon, MBA, Community Oncology Alliance

October 25th 2023

Innovating Community Oncology Care Delivery and Payment Reform: Insights From COA’s Ted Okon

Maggie L. Shaw

Ted Okon, MBA, executive director, Community Oncology Alliance, discusses early returns from the Enhancing Oncology Model and how community oncology practices are innovating in ways that can expand into other areas of medicine.

Miriam J. Atkins, MD, FACP, Community Oncology Alliance/AO Multispecialty Clinic

October 24th 2023

Dr Miriam J. Atkins: Each One of Us Needs Everyone Else

Maggie L. Shaw

Miriam J. Atkins, MD, FACP, president of the Community Oncology Alliance, discusses the challenges facing oncology today, such as physician and nurse recruitment and minority clinical trial enrollment.

October 23rd 2023

Dr Lalan Wilfong: Patients Deserve the Full Benefit of Everything We Can Provide

Maggie L. Shaw

At the 2023 COA Payer Exchange Summit being held October 23-24 in Reston, Virginia, Lalan Wilfong, MD, US Oncology Network, emphasizes the importance of oncology care equity, ensuring continuity of care, and enhancing care coordination.

Stomach cancer art | Image credit: Crystal light - stock.adobe.com

October 20th 2023

Frontline Pembrolizumab Plus Trastuzumab/Chemotherapy Improves PFS in HER2+ Gastric/GEJ Cancer

Ryan Scott

Adding pembrolizumab to combination of trastuzumab and chemotherapy improved progression-free survival vs placebo plus trastuzumab and chemotherapy in the first-line treatment of patients with metastatic HER2-positive gastric or gastroesophageal junction (GEJ) cancer.

noted Joelle Hicks, BSN, RN | Image Credit: Summa Health

October 17th 2023

Streamlined Referral Intervention Sees Great Success Among Patients With Head/Neck Cancer

Maggie L. Shaw

A 2022 yearlong initiative at Summa Health Cancer Institute saw 100% of its patients with head and neck cancer undergoing radiation treatment referred to an oncology dietician for nutritional support and/or speech and swallow therapy.

Surgery | Image credit: Surgery_Gorodenkoff - stock.adobe.com.jpeg

October 13th 2023

Treating Hepatobiliary Cancer With Transplant, Resection, or Radiation

Laura Joszt, MA

Knowledge of the different treatment options available and the eligibility criteria for each will help identify the right treatment for patients with hepatobiliary cancer.

October 6th 2023

Updated Survey: NCCN Centers Say Chemo Shortage Has Ebbed Only Slightly

Mary Caffrey

The survey, completed over 2 weeks in September, follows a similar one released in June.

September 14th 2023

Characteristics of Self-Triaged Emergency Department Visits by Adults With Cancer

Arthur S. Hong, MD, MPH Amy Hughes, PhD D. Mark Courtney, MD, MSCI Hannah Fullington, MPH Simon J. Craddock Lee, PhD, MPH John W. Sweetenham, MD Navid Sadeghi, MD, MSPH Song Zhang, PhD Angela Bazzell, DNP, APRN, FNP-BC, AOCNP Ethan A. Halm, MD, MPH, MBA

Adults with cancer may have difficulty self-assessing the clinical severity of their acute care needs, yet they rarely use a telephone triage line available to them.

September 11th 2023

Comparison of Primary Payer in Cancer Registry and Discharge Data

Youngmin Kwon, BA Marcelo C. Perraillon, PhD Coleman Drake, PhD Bruce L. Jacobs, MD, MPH Cathy J. Bradley, PhD Lindsay M. Sabik, PhD

Enrollment in managed care among Medicaid enrollees presents challenges to classifying Medicaid coverage in cancer registries.

August 28th 2023

Dr Carmen Solórzano Explains VICC’s Tumor Boards, Implementing Patient Preferences

Brooke McCormick

Carmen Solórzano, MD, FACS, of Vanderbilt University Medical Center, discusses how Vanderbilt-Ingram Cancer Center (VICC) conducts tumor boards and explains how patient preferences are considered during them.

...

7 8 9 10 11 12 13 14 15

...

185 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions